Germany
,05 July 2022
Billion-Euro market biotechnology: Exyte builds mRNA competence center for WACKER in Halle
Exyte GmbH (Exyte), a global leader in the design, engineering and delivery of facilities for high-tech industries, is building a mRNA competence center at the Halle Biotech site of Wacker Chemie AG (WACKER). The project is making a considerable contribution towards strengthening the Biopharma and Life Sciences segment at Exyte as well as to the company’s ambitious “Pathway to Ten” growth path
Loading….